Total Payments
$4,549
2024 Payments
$570.38
Companies
22
Transactions
156
Medicare Patients
5,534
Medicare Billing
$476,212
Payment Breakdown by Category
Food & Beverage$4,180 (91.9%)
Other$332.97 (7.3%)
Education$35.68 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,180 | 153 | 91.9% |
| Entertainment | $332.97 | 1 | 7.3% |
| Education | $35.68 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,114 | 37 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $636.30 | 29 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $430.36 | 19 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $370.79 | 4 | $0 (2020) |
| Marco Ophthalmic, Inc. | $332.97 | 1 | $0 (2017) |
| ABBVIE INC. | $295.19 | 16 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $178.22 | 4 | $0 (2021) |
| Shire North American Group Inc | $167.66 | 8 | $0 (2019) |
| Omeros Corporation | $125.00 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $124.78 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $570.38 | 29 | ABBVIE INC. ($141.28) |
| 2023 | $512.83 | 26 | Sun Pharmaceutical Industries Inc. ($224.66) |
| 2022 | $712.54 | 30 | Sun Pharmaceutical Industries Inc. ($297.13) |
| 2021 | $474.52 | 23 | Allergan, Inc. ($152.05) |
| 2020 | $372.01 | 9 | Allergan, Inc. ($192.43) |
| 2019 | $522.54 | 14 | Allergan Inc. ($205.95) |
| 2018 | $592.24 | 17 | Allergan Inc. ($223.33) |
| 2017 | $791.86 | 8 | Marco Ophthalmic, Inc. ($332.97) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: EYE CARE | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Dry eyes | ||||||
| 10/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: EYE CARE | ||||||
| 10/01/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/19/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: EYE CARE | ||||||
| 08/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: EYE CARE | ||||||
| 08/23/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Ophthalmology | ||||||
| 07/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: EYE CARE | ||||||
| 06/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: EYE CARE | ||||||
| 05/16/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $17.08 | General |
| 04/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: EYE CARE | ||||||
| 03/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,433 | 1,880 | $431,200 | $132,190 |
| 2022 | 11 | 1,435 | 1,866 | $348,225 | $126,820 |
| 2021 | 13 | 1,406 | 1,780 | $383,275 | $124,999 |
| 2020 | 15 | 1,260 | 1,485 | $358,225 | $92,202 |
Total Patients
5,534
Total Services
7,011
Medicare Billing
$476,212
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 537 | 772 | $154,400 | $73,298 | 47.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 136 | 207 | $31,050 | $15,285 | 49.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 265 | 318 | $63,600 | $9,263 | 14.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 86 | 86 | $17,200 | $8,606 | 50.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 135 | 156 | $23,400 | $7,907 | 33.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 25 | 28 | $84,000 | $7,724 | 9.2% |
| 92134 | Imaging of retina | Office | 2023 | 102 | 125 | $25,000 | $3,907 | 15.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 11 | 30 | $6,000 | $2,983 | 49.7% |
| 92250 | Photography of the retina | Office | 2023 | 32 | 32 | $8,000 | $951.16 | 11.9% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 18 | 34 | $5,100 | $749.02 | 14.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 29 | 31 | $3,100 | $658.17 | 21.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 29 | 33 | $8,250 | $633.77 | 7.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 28 | 28 | $2,100 | $225.48 | 10.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 489 | 709 | $141,800 | $69,096 | 48.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 145 | 254 | $38,100 | $18,115 | 47.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 97 | 97 | $19,400 | $10,132 | 52.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 158 | 180 | $27,000 | $9,261 | 34.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 278 | 311 | $62,200 | $9,111 | 14.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 12 | 37 | $7,400 | $3,964 | 53.6% |
| 92134 | Imaging of retina | Office | 2022 | 95 | 106 | $21,200 | $3,727 | 17.6% |
| 92250 | Photography of the retina | Office | 2022 | 51 | 52 | $13,000 | $1,603 | 12.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 34 | 36 | $3,600 | $758.75 | 21.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 39 | 47 | $11,750 | $754.49 | 6.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 37 | 37 | $2,775 | $297.94 | 10.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 449 | 616 | $123,200 | $60,484 | 49.1% |
About Dr. Debra Guthrie, MD
Dr. Debra Guthrie, MD is a Glaucoma Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215967740.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Guthrie, MD has received a total of $4,549 in payments from pharmaceutical and medical device companies, with $570.38 received in 2024. These payments were reported across 156 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,180).
As a Medicare-enrolled provider, Guthrie has provided services to 5,534 Medicare beneficiaries, totaling 7,011 services with total Medicare billing of $476,212. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Ophthalmology
- Location New York, NY
- Active Since 07/03/2006
- Last Updated 10/01/2021
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1215967740
Products in Payments
- LUMIGAN (Drug) $701.03
- Cequa (Drug) $612.32
- OPD-III (Device) $332.97
- XIIDRA (Drug) $309.23
- VYZULTA (Drug) $297.22
- Rhopressa (Drug) $259.30
- RESTASIS (Drug) $215.75
- DURYSTA (Drug) $156.81
- OMIDRIA (Drug) $125.00
- EYLEA (Biological) $124.78
- LOTEMAX SM (Drug) $122.56
- rhopressa (Drug) $111.49
- INVELTYS (Drug) $109.91
- TearCare SmartLid (Device) $102.15
- MIEBO (Drug) $87.99
- TYRVAYA (Drug) $81.19
- XDEMVY (Drug) $76.24
- COMBIGAN (Drug) $63.21
- EYSUVIS (Drug) $53.47
- VUITY (Drug) $52.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in New York
Jeffrey Liebmann, Md, MD
Glaucoma Specialist — Payments: $175,452
Glaucoma Specialist $175,452
Sarah Vantassel, Md, MD
Glaucoma Specialist — Payments: $66,165
Glaucoma Specialist $66,165
Dr. Yuna Rapoport, M.d, M.D
Glaucoma Specialist — Payments: $50,022
Glaucoma Specialist $50,022
Aakriti Shukla, M.d, M.D
Glaucoma Specialist — Payments: $41,163
Glaucoma Specialist $41,163
Dr. Sonya Dhar, Md, MD
Glaucoma Specialist — Payments: $20,404
Glaucoma Specialist $20,404
Luis Silva Alvarez, M.d, M.D
Glaucoma Specialist — Payments: $7,831
Glaucoma Specialist $7,831